Search - tctmd.com

Displaying 121 - 140 of 1162

Sort: Relevancy | Date

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Conference News HFSA 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Todd Neale

October 01, 2024

News Daily News

Deprescribing Antihypertensives May Slow Cognitive Decline in Nursing Home Patients

L.A. McKeown

September 27, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Liraglutide Helps Shed Weight in Young Children With Obesity

Todd Neale

September 13, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Yael L. Maxwell

August 31, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

Advertisement

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

AHA Statement Outlines Cardiac Contributions to Brain Health

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Deprescribing Antihypertensives May Slow Cognitive Decline in Nursing Home Patients

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Liraglutide Helps Shed Weight in Young Children With Obesity

Statins Are Cost-effective in the Elderly

TCTMD’s Top 10 Most Popular Stories for August 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

September 2024 Dispatch for the CV Team

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Polypills Show Promise in Diverse Hypertensive Patient Groups

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content